— Know what they know.
Not Investment Advice

TSVT NASDAQ

2seventy bio, Inc.
1W: +0.0% 1M: +0.8% 3M: +104.1% 1Y: +11.6% 3Y: -64.3%
$5.00
Last traded 2025-05-12 — delisted
NASDAQ · Healthcare · Biotechnology · $266.1M mcap · 43M float · 3.42% daily turnover · Short 55% of daily vol

Cash Flow Trends

Operating Cash Flow
-$85M +49.1% ▲
Capital Expenditures
$707K +94.9% ▲
5Y CAGR: -58.8%
Free Cash Flow
-$86M +52.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$4M -186.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$120M-$292M-$254M-$218M-$57M
Depreciation & Amort.$13M$16M$12M$10M$7M
Stock-Based Comp.$61M$55M$41M$32M$12M
Change in Working Capital-$15M$13M-$36M$3M$3M
Other Non-Cash Items-$6M$869K$317K$6M-$50M
Operating Cash Flow-$68M-$207M-$237M-$167M-$85M
— Investing Activities —
Capital Expenditures-$22M-$20M-$23M-$14M-$707K
Acquisitions (Net)$0$0-$35M$0$0
Investment Purchases$0$0-$146M-$247M-$127M
Investment Sales$0$35M$180M$305M$167M
Other Investing$0-$33M$35M-$430K$42M
Investing Cash Flow-$22M$15M$12M$44M$81M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$90M$355M$696K$527K$417K
Financing Cash Flow$90M$355M$166M$127M$417K
Net Change in Cash$0$163M-$59M$4M-$4M
Cash End of Period$0$163M$104M$77M$73M
Free Cash Flow-$90M-$227M-$260M-$181M-$86M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms